THL – TorHoerman Law

Gadolinium Gadolinium contrast agents are causing a rare disease

Gadolinium Lawsuit

Individuals who have been injured as a result of using Gadolinium may qualify to participate in the Gadolinium lawsuit.

In April 2017, manufacturers and plaintiffs in the Gadolinium lawsuit agree to a $33.9 million settlement.

At this time, TorHoerman Law is no longer taking Gadolinium lawsuit cases.

Litigation Updates

See More

Gadolinium Lawsuit

Gadolinium contrast agents, used to enhance MRI films, can be extremely dangerous for people with kidney problems. Over the past several years it has become apparent that gadolinium contrast dyes are causing a rare and debilitating disease called Nephrogenic Systemic Fibrosis (NSF).


What is NSF?

NSF is a relatively new disease, with the first diagnosis of NSF occurring in 1997. Currently, the Center for Disease Control has information about 315 patients with NSF. Sadly, at the present time, there are more questions than there are answers about the disease. There are very few effective treatments for NSF, and there is no cure. 


Do I need to worry about developing NSF/NSD when getting an MRI or MRA scan?

NSF/NSD is a rare diagnosis. There have been no reports of NSF in patients with normal kidney function or with those with mild-to-moderate kidney insufficiency. However, if you suspect you may have kidney issues, you should be screened prior to receiving one of these imaging agents. Furthermore, the recommended dose should not be exceeded and enough time should elapse to ensure that a dose has been eliminated from the body before the agent is used again.

What are the initial signs of the rare and serious syndrome NSF/NFD? 

Originally thought to be a skin disorder, the diagnosis was termed nephrogenic fibrosing dermopathy (NFD). Gradually, the diagnosis produced wider symptoms and it is now considered a systemic disorder referred to as nephrogenic systemic fibrosis (NSF). Some of the initial signs of NSF/NSD are:

  • Development of tight, rigid skin in areas
  • Scarring of body organs
  • Burning, itching, swelling, hardening and tightening of the skin
  • Red or dark patches on the skin
  • Yellow spots on the whites of eyes
  • Stiffness in joints with trouble moving or straightening the arms, hands, legs or feet
  • Pain deep in the hip bones or ribs
  • Muscle weakness


What is Gadolinium?

Gadolinium (Gd) is a silvery-white, malleable and ductile rare-earth metal. Because of extremely high neutron cross-section of gadolinium, this element is very effective for use with neutron radiography An MRI scan provides clear and detailed pictures of internal organs.

Gadolinium contrast dyes were approved for use in MRI scans in 1988. Gadolinium quickly became the preferred contrast agent for use in patients with chronic kidney disease.

By 1997, the first known diagnosis of NSF linked to Gadolinium was recorded. In September 2000, details of NSF are published in the medical journal Lancet.

There are currently five gadolinium contrast dyes on the market:

  • Omniscan by GE Healthcare
  • OptiMARK by Mallinckordt/Tyco Healthcare
  • Magnevist by Bayer/Schering AG/Berlex
  • ProHance by Bracco Diagnostics
  • MultiHance by Bracco Diagnostices



+ - References

"Gadolinium-Based Contrast Agents (GBCAs) and Nephrogenic Systemic Fibrosis (NSF)." DIVISION OF MEDICAL IMAGING AND HEMATOLOGY PRODUCTS MEMORANDUM TO THE FILE,,021358s013lbl.pdf

No-Obligation Free Consultation

Contact us by phone at (618) 656-4400 or email us below.

Sidebar Contact

Your information will be used only so that we may contact you to evaluate your case. Your contact information will never be shared or sold to anyone other than TorHoerman Law.